MedTrace Logo

Prostate Embolization for Acute Urinary Retention Study

NCT02689830 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2017-07-21

No results posted yet for this study

Summary

The purpose of this study is to assess the feasibility and safety of Prostate Artery Embolization (PAE) in patients suffering of Acute Urinary Retention (AUR) in the context Benign Prostatic Hypertrophy (BPH).

Conditions

  • Prostatic Hypertrophy, Benign

Interventions

DEVICE

Bead Block

Prostate embolization

Sponsors & Collaborators

  • Biocompatibles UK Ltd

    collaborator INDUSTRY

  • European Georges Pompidou Hospital

    collaborator OTHER

  • ClinSearch

    lead OTHER

Principal Investigators

  • Marc SAPOVAL · HEGP, Paris

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-07-31
Completion
2017-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02689830 on ClinicalTrials.gov